期刊文献+

干扰素α-2b清除宫颈人乳头瘤病毒感染对维吾尔族妇女的影响 被引量:1

The effect of interferon therapy of human papilloma virus infection in Xinjiang Uygur women
下载PDF
导出
摘要 目的观察干扰素α-2b栓对宫颈人乳头瘤病毒(HPV)感染清除的疗效。方法经基因芯片技术检测为HPV感染的新疆维吾尔族宫颈炎患者125例,根据自愿原则分为研究组(80例)及对照组(45例)。研究组患者使用干扰素仅一2b栓治疗,对照组患者则定期监测HPV的变化,均每3个月复查一次HPV。结果研究组与对照组高危型HPV感染例数分别为87和49例。12个月后,研究组与对照组高危型HPV感染清除率分别为97.7%(85/87)和91.8%(45/49),组间差异无统计学意义(P〉0.05)。第3、6、9个月研究组的清除率均高于对照组,组间差异均有统计学意义[3个月:60.9%(53/87)比40.8%(20/49);6个月:90.8%(79/87)比59.2%(29/49);9个月:95.4%(83/87)比71.4%(35/49),P〈0.05]。结论干扰素α-2b栓在一定程度上提高了宫颈高危型HPV感染的清除率,对防止宫颈病变有一定作用。 Objective To research the effect of α-2b-interferon suppository on cervical human papilloma virus(HPV) infection. Methods A total of 125 cases of Xinjiang Uygur cervicitis patients with high-risk HPV infection were divided into study group( 80 cases)and control group(45 cases ). HPV types were detected through gene chip technology. Patients in study group were treated by interferon α-2b. Results After 12 months, the clearance rate of high-risk HPV in patients of study group and control group was 97.7% (85/87)and 91.8% (45/49)respectively ( P 〉 0. 05 ). 1,3,6,9-month clearance rates of study group and control group were compared and the differences were statistically significant [ 60. 9% ( 53/87 ) vs 40. 8% ( 20/49 ), 90. 8% ( 79/87 ) vs 59.2% ( 29/49 ), 95.4% ( 83/87 ) vs 71.4% ( 35/49 ), all P 〈 0.05 ]. Conclusion Interferon alpha suppository can improve cervical high-risk HPV infection clearance rate and prevent cervical disease.
作者 韩莉莉 王琳
出处 《中国医药》 2012年第3期354-355,共2页 China Medicine
关键词 人乳头瘤病毒感染 子宫颈 干扰素 维吾尔族 Human papilloma virus infection Cervix uteri Interferon Uighur
  • 相关文献

参考文献9

  • 1Clifford GM, Smith JS, Plummer M, et al. Human papillomavirus types in invasive cervical cancer worldwide : a meta-analysis. Br J Cancer,2003,88( 1 ) :63-73.
  • 2Hwang TS, Jeong JK, Park M, et al. Detection and typing of HPV genotypes in various cervical lesions by HPV oligonucleotide mi- croarray. Gynecol Onco1,2003,90( 1 ) :51-56.
  • 3闻正梅.现代医学微生物学.上海:上海医科大学出版社,1999:957-970.
  • 4Wilson VG, West M, Woytek K, et al. Papillomavirus E1 proteins : form, function, and features. Virus Genes, 2002,24 ( 3 ) : 275-290.
  • 5Kulmala SM, Shabalova IP, Petrovitchev N, et al. Type-specific per- sistence of high-risk human papillomavirus infections in the New In- dependent States of the former SovietUnion Cohort Study. Cancer Epidemiol Biomarkers Prev,2007,16 ( 1 ) : 17 -22.
  • 6Clifford GM, Gallus S, Herrero R, et al. Worldwide distribution of human papillomavirns types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence sur- veys : a pooled analysis. Lancet,2005,366 (9490) :991-998.
  • 7吴满武.妇科门诊518例就诊者宫颈拭子HPV检测结果分析[J].中国优生与遗传杂志,2009,17(4):77-78. 被引量:23
  • 8赵超,魏丽惠.干扰素α-2b对宫颈癌细胞HPV16 E6E7基因抑制作用的研究[J].中国妇产科临床杂志,2005,6(3):192-195. 被引量:14
  • 9李雪梅,李彩琴.爱宝疗液配伍奥平治疗宫颈糜烂临床体会[J].中国社区医师(医学专业),2009,11(14):90-90. 被引量:7

二级参考文献23

  • 1郎景和.子宫颈病变防治的几个问题[J].世界医学杂志,2004,8(11):1-3. 被引量:84
  • 2Meisels A, Fovtin R, Roy M. Condylomatous lesions of the cerix II. Cytologic , colposcopic and histopathologic study [ J ]. Acta cytol , 1977,21 (3) :379 -390.
  • 3Bachtiary B, Obemair A, Dreier B, et al. Impact of multiple HPV infection on response to trentment and survival in patients receiving radical radiotheraphy for cervical cancer [ J ]. Int J Cancer, 2002,102 : 237.
  • 4Lee SA , Kang D, Seo SS, et al. Multiple HPV infection in cervieal cancer screened by HPV DNA chip[ J ]. Cancer Lett,2003, 198 (2) : 187.
  • 5Clifford GM, Smith JS, Plummer M, et al. Human papiUomavirus types in invasive cancer worldwide : a meta - analysis[ J]. Br J Cancer ,2003,88:63-73.
  • 6Cuzick J, Szarewski A , Terry G, et al . Human papillomavirus testing in primary cervical screening [ J ]. Lancet , 1995,345 : 1533 - 1536.
  • 7Jenkins D, Shetlaw Johnnaon C, Gallivan S. Can papillomavirus testing be used to improve cervical cancer screening? [ J ]. lnt J Cancer, 1996,65:768 - 773.
  • 8[2]Munoz N,Bosch FX,Sanjose S,et al.Epidemiologic classification of humanpapillomavirus types associated with cervical cancer.N Engl J Med,2003,348:518-527.
  • 9[3]Einstein MH,Goldberg GL.Human papillomavirus and cervical neoplasia.Cancer Invest,2002,20:1080-1085.
  • 10[4]Bosch FX,Munoz N.The viral etiology of cervical cancer.Virus Res,2002,89:183-190.

共引文献41

同被引文献9

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部